These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2537698)

  • 1. Calcium entry blockade and alpha-adrenergic vascular reactivity in human beings: differences between nicardipine and verapamil.
    Pedrinelli R; Taddei S; Salvetti A
    Clin Pharmacol Ther; 1989 Mar; 45(3):285-90. PubMed ID: 2537698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous interference of nicardipine, verapamil, and diltiazem with forearm arteriolar responsiveness to adrenergic stimulation in hypertensive patients.
    Pedrinelli R; Salvetti A
    Am Heart J; 1991 Jul; 122(1 Pt 2):342-51. PubMed ID: 2053555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium entry blockade and adrenergic vascular reactivity in hypertensives: differences between nicardipine and diltiazem.
    Pedrinelli R; Panarace G; Salvetti A
    Clin Pharmacol Ther; 1991 Jan; 49(1):86-93. PubMed ID: 1671009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium entry blockade and agonist-mediated vasoconstriction in hypertensive patients.
    Pedrinelli R; Taddei S; Panarace G; Spessot M; Salvetti A
    J Cardiovasc Pharmacol; 1990; 16 Suppl 2():S34-9. PubMed ID: 1369706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium entry blockade and agonist-mediated forearm vasoconstriction in hypertensive patients. Difference between nicardipine and verapamil.
    Pedrinelli R; Taddei S; Panarace G; Spessot M; Salvetti A
    Eur J Clin Pharmacol; 1991; 40(1):1-5. PubMed ID: 2060535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interference by nicardipine and diltiazem on alpha-adrenergic receptor-mediated vasoconstriction in isolated human subcutaneous arterioles.
    Spessot M; Pedrinelli R
    Clin Pharmacol Ther; 1993 Jul; 54(1):70-5. PubMed ID: 8392458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil and alpha-mediated vasoconstriction in human forearm: a comparison between norepinephrine and selective alpha 1- and alpha 2-adrenergic agonists.
    Pedrinelli R; Taddei S; Graziadei L; Pana-Race G; Salvetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S48-52. PubMed ID: 2455139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil antagonizes forearm vasoconstriction mediated by selective alpha 1- and alpha 2-agonists in hypertensive patients.
    Pedrinelli R; Taddei S; Graziadei L; Panarace G; Salvetti A
    J Hypertens Suppl; 1986 Dec; 4(5):S451-4. PubMed ID: 2883272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of sympathetic-mediated forearm vasoconstriction after alpha-blockade in hypertensive patients.
    Taddei S; Salvetti A; Pedrinelli R
    Circulation; 1989 Sep; 80(3):485-90. PubMed ID: 2569947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium influx mediated vasoconstriction: studies in patients with mild and moderate essential hypertension.
    Hulthén UL; Bolli P; Bühler FR
    J Hypertens Suppl; 1983 Dec; 1(2):105-8. PubMed ID: 6599487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ouabain vasoconstricts human forearm arterioles through alpha-adrenergic stimulation.
    Taddei S; Salvetti A; Pedrinelli R
    J Hypertens Suppl; 1988 Dec; 6(4):S357-9. PubMed ID: 2853745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilatory effect of nicardipine and verapamil in the forearm of hypertensive as compared with normotensive man.
    Hulthén UL; Bolli P; Bühler FR
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):62S-66S. PubMed ID: 3896282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limb vasoconstriction after successful angioplasty of the left anterior descending coronary artery.
    Indolfi C; Piscione F; Ceravolo R; Maione A; Focaccio A; Rao MA; Esposito G; Condorelli M; Chiariello M
    Circulation; 1995 Oct; 92(8):2109-12. PubMed ID: 7554189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forearm vascular alpha 1-adrenergic blockade by verapamil.
    Abernethy DR; Winterbottom LM
    Clin Pharmacol Ther; 1990 Jun; 47(6):755-9. PubMed ID: 2162750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venoconstriction by angiotensin II in the human forearm is inhibited by losartan but not by nicardipine.
    Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):50-5. PubMed ID: 9456277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of calcium entry blockade in vivo with pressor responses to alpha-adrenergic stimulation: effects of two unrelated blockers on responses to both exogenous and endogenously released norepinephrine.
    Pedrinelli R; Tarazi RC
    Circulation; 1984 Jun; 69(6):1171-6. PubMed ID: 6143626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenaline induces vasoconstriction through post-junctional alpha 2 adrenoceptors and this response is enhanced in patients with essential hypertension.
    Bolli P; Erne P; Ji BH; Block LH; Kiowski W; Bühler FR
    J Hypertens Suppl; 1984 Dec; 2(3):S115-8. PubMed ID: 6100732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil interacts in vitro with alpha 2-adrenoceptors but does not modify alpha 2-receptivity in vivo.
    Galinier M; Senard JM; Valet P; Boneu B; Galinier F; Montastruc JL
    Arch Int Pharmacodyn Ther; 1989; 301():30-9. PubMed ID: 2576196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ouabain-induced elevation in forearm vascular resistance, calcium entry and alpha-adrenoceptor blockade, and release and removal of noradrenaline.
    Schulte KL; van Gemmeren D; Thiede HM; Meyer-Sabellek W; Gotzen R; Distler A
    J Hypertens Suppl; 1987 Dec; 5(5):S215-8. PubMed ID: 2895170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of calcium entry blockade on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in the forearm of hypertensive patients.
    Jie K; van Brummelen P; Vermey P; Timmermans PB; van Zwieten PA
    Eur J Clin Pharmacol; 1987; 32(2):115-20. PubMed ID: 3034623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.